Doximity Inc. (NYSE:DOCS) reported second-quarter CY2026 financial results that exceeded revenue forecasts, driven by strong adoption of its artificial intelligence tools across its clinician network. The company announced the results on Tuesday, showing year-over-year revenue growth supported by increased utilization of its AI-assisted documentation and telehealth services.
According to the earnings release, Doximity generated $142.3 million in revenue for the quarter, surpassing the consensus estimate of $135.1 million. This represents a 14% increase compared to the same period last year. The growth was primarily attributed to higher engagement on its platform, where over 80% of U.S. physicians are now active users, according to internal company data.
Our AI-powered tools are reducing administrative burden for clinicians while improving workflow efficiency, said Dennis Shaughnessy, CEO of Doximity, in the earnings call. We’re seeing deeper integration of our products into daily clinical practice, which translates to sustained value for both users and health systems.
The company’s Clinical Cloud suite, which includes AI-driven note generation and patient referral management, saw a 22% quarter-over-quarter increase in paid subscriptions. Doximity also noted that its telehealth visit volume remained stable, with over 1.2 million virtual visits facilitated through its platform during the quarter.
Analysts noted that Doximity’s ability to monetize its network through premium subscriptions and data insights continues to differentiate it from broader telehealth competitors. The company maintained its full-year CY2026 revenue guidance between $560 million and $570 million, reflecting confidence in continued demand for its integrated workflow solutions.
Beyond financial performance, Doximity emphasized its ongoing investments in AI safety and bias mitigation, particularly in clinical decision support features. The company stated it is collaborating with academic medical centers to validate the accuracy and equity of its algorithms across diverse patient populations.
Doximity’s AI Strategy Fuels Long-Term Network Value
Doximity’s competitive advantage lies in its verified network of healthcare professionals, which enables targeted deployment of AI tools that integrate seamlessly into existing workflows. Unlike generic AI applications, Doximity’s solutions are built on real-world clinical use cases, enhancing adoption and reducing friction.
The company plans to expand its AI offerings later in CY2026, including predictive analytics for patient no-shows and automated prior authorization assistance. These tools aim to further reduce administrative overhead, a persistent pain point in U.S. healthcare delivery.
Doximity continues to operate as a key digital infrastructure provider in the U.S. healthcare system, with over 2 million verified members across physicians, nurse practitioners, and physician assistants. Its platform remains free for individual clinicians, with revenue generated through premium subscriptions, talent solutions, and health system licensing.
Key questions
- What drove Doximity's revenue beat in Q2 CY2026?
- Doximity's Q2 CY2026 revenue growth was driven by increased adoption of its AI-powered clinical tools, particularly in documentation and workflow management, which boosted engagement across its verified network of U.S. physicians and health systems.
- Is Doximity profitable, and what is its outlook for the rest of CY2026?
- While Doximity did not disclose profitability details in the summary, it reaffirmed its full-year CY2026 revenue guidance of $560 million to $570 million, indicating confidence in sustained demand for its platform and AI-enabled services.
